All In MedTech

Device Trial Radar · NCT05856799

Danish Randomized Trial on Leadless vs Transvenous Pacing

Danish Randomized Trial on VDD Leadless Atrial Tracking With MicraTM AV Transcatheter Pacing System vs Transvenous DDD Pacing in Elderly Patients With AV-block

Last checked: Nov 20, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Sep 1, 2023

Primary completion

Nov 2026

Study completion Nov 2028

Sponsor

Lead sponsor
University of AarhusAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Aarhus University Hospital; Odense University Hospital
First posted
May 12, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the quality of life, patient acceptance and exercise capacity with leadless compared to transvenous pacing in elderly patients with new-onset high-grade atrioventricular block. Consecutive patients with high-grade atrioventricular black and preserved sinus node function with indication for permanent pacemaker implantation according to the latest european guidelines, are included in a prospective, partly patient and accessor blinded and partly open label, 1:1 randomized combined parallel and cross-over trial to implantation with 1) a Micra AV Transcathter Pacing System or 2) an Azure XT DR dual chamber pacemaker.

Conditions

  • AV Block

Interventions

  • Leadless Micra AV Transcatheter Pacing SystemDevice

    Patients are implanted with a leadless Micra AV TPS

  • Transvenous Azure XT DR dual chamber pacemakerDevice

    Patients are implanted with a transvenous Azure XT DR pacemaker

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Quality of Life by SF36Time frame: 7 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Department of Cardiology Aarhus University Hospital

    Aarhus, Region Midt, Denmark

  • Department of Cardiology Odense University Hospital

    Odense, Region Syd, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.